Skip to content
OpenCapital
Get started

Viemed Healthcare, Inc. VMD Equity Securities (Non-Current)

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%—

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFVNINoncurrent.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s equity securities (non-current).

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s equity securities (non-current)?
Viemed Healthcare, Inc. (VMD) reported equity securities (non-current) of $2.79M in Q1 2026.
How has Viemed Healthcare, Inc.'s equity securities (non-current) changed year-over-year?
Viemed Healthcare, Inc.'s equity securities (non-current) decreased by 0.0% year-over-year, from $2.79M to $2.79M.
What is the long-term trend for Viemed Healthcare, Inc.'s equity securities (non-current)?
Over 2 years (2023 to 2025), Viemed Healthcare, Inc.'s equity securities (non-current) has grown at a 29.0% compound annual growth rate (CAGR), from $1.68M to $2.79M.